* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
Today, Kibo Energy (KIBO.L) left AIM.
Last Friday, CPP Group (CPP.L) left AIM.
Market Movers:
Last Friday, Volex (VLX.L) moved from AIM to the Main Market.
What’s baking in the oven?
It's a little empty
Banquet Buffet****
London Stock Exchange: Main Market and AIM
80 Mile 0.70p £39.58m (80M.L)
The exploration and development Company with projects in Greenland, Finland and Italy, announced a placing to raise approximately £1.9m at a price of 0.67 pence per Ordinary Share. The CEO commented that preparations for the fully funded two-well drilling campaign at Jameson are well advanced and the programme will test one of the largest remaining undrilled conventional hydrocarbon basins in the Western world.
AOTI, Inc 97.50p £93.06m (AOTI.L)
The medical technology Company focused on the healing of wounds and prevention of amputations announced its trading update for the six months ended 30 June 2026. The Company delivered 10% revenue growth to c.$35m (H1 25: $31.8m) and cash of c.$13.8m at 30 June 2026 (FY 25: $13.4m). The Company expects to announce its interim results for the six months ended 30 June 2026 on 30 September 2026.
Cambridge Cognition Holdings 32.50p £17.56m (COG.L)
The neuroscience technology Company announced a trading update for the period ended 30 June 2026. Revenue of £5.0m, up 16% (H1 2025: £4.3m) including first revenues from the Company's new Healthcare and Consumer Wellness pilots of £0.1m. The order book on 30 June 2026 was £16.1m (30 June 2025: £16.4m), which excludes the July £1.0m contract. Positive operational cash flow in H1 and cash of £0.6m at 30 June 2026 (30 June 2025: cash outflow £(0.3)m). Reduced borrowings of £0.2m (December 2025: £0.9m), resulting in an increased net cash position of £0.4m (December 2025: net cash £0.3m). The Board remains confident in meeting market expectations for the FY2026 of consensus forecasts: revenues of £11.35m and adjusted Loss before tax of £1.25m.
Dianomi 21.50p £6.46m (DNM.L)
The provider of digital advertising services announced an unaudited update on trading for the 6 months to 30 June 2026. The Group expects to deliver revenues of £13.4m (H125: £13.2m), representing growth of 2% year on year and gross profit increased to £3.9m (H125: £3.3m), representing a margin of 28.9% (H125: 25.3%). The Group expects to recognise a small loss at the EBITDA level which is improved on the prior year (H125: loss of £0.6m). Cash as at 30 June 2026 was £6.0m (30 June 2025: £5.7m, 31 December 2025: £5.8m), reflecting positive cash flow in the period despite the EBITDA loss, and the Group remains debt free.
Pathos Communications 29.00p £18.33m (NEWS.L)
The PR technology business announced a trading update for the half year ended 30 June 2026. Revenue for H1 2026 is expected to be US$7.3m, up 14% on the prior year (H1 2025: US$6.4m) and Adjusted EBITDA in H1 2026 is expected to be US$1.7m, up 31% on the prior year (H1 2025: US$1.3m). Net cash as at 30 June 2026 was US$5.9m, ahead of market expectations (US$6.2 million as at 31 December 2025). The Board remains confident in meeting market expectations for the FY 2026.
RTC Group 95.0p £11.3m (RTC.L)
The engineering and technical recruitment Group reports interims to 30 June 2026. Revenue is 6.4% lower at £45.2m with 38% lower operating profits at £0.8m. There is no term debt and the cash is £3.8m compared to £3.9m in the H1 2025 and the dividend is being increased 10% to 5.5p. There is a strong and sustainable order book across all sectors with six significant contract wins and extensions, including long-term agreements with key clients. The geopolitical and domestic economic environments are, however, worrying and could continue to present challenges in the short to medium term. The CEO states that the strong balance sheet, no term debt, continued operating cash generation and disciplined cost management aligned to activity levels is a solid platform to navigate the current environment.
Shearwater Group 56.50p £10.84m (SWG.L)
The cybersecurity, advisory, and managed security services Group provided an update on trading for the year to 30 June 2026 (FY26). Revenue and adjusted EBITDA are now anticipated to be ahead of market expectations with expected revenue of c.£42m, representing an annualised YoY increase of c.33% (FY25: £39.5m for 15-month period), and expected adjusted EBITDA of £2.5m, an annualised increase of 41% (FY25: £2.2m). The Group finished the period with net cash of £5.6m (FY25: £5.1m) and the Board remains confident in the Group's prospects for the year ahead.
Warpaint London 187.5p £147.03m (W7L.L)
The supplier of cosmetics and personal care brands announced the commencement of an initial share buyback programme up to a maximum aggregate consideration of £2.5m. The Programme will commence immediately and will end no later than 31 December 2026. Ordinary Shares acquired under the Programme will be held in treasury and are expected to be used to satisfy future obligations from Warpaint's employee share schemes, thus reducing future dilution for shareholders. The Board believes that the Programme represents an effective use of the Group's cash balances, which stood at £20.6m in total as at 30 June 2026.
Zinc Media Group 56.50p £17.17m (ZIN.L)
The television and content production Group updates on trading for the six months to 30 June 2026. The pipeline for recognition in FY26 is £34m, with a further £3m in advanced conversations compared to £40m in 2025. The Middle East business is outperforming FY26 growth expectations, but there are headwinds in the market and this may impact the delivery of some large productions due in H2. Cash at the end of June is £2.7m compared to £4.2m in June 2025, reflecting payment of £0.33m in relation to The Edge final earn out payment as well as a £0.34m on one-off restructuring costs to deliver £1m of annual savings. The three strategic priority growth pillars announced in April last year are all performing well after their first year and underline the Group's strong track record of organic investment. The Group has targeted growth of £10m of revenue across these three strategic pillars by the end of 2028.
Aquis Market
Ajax Resources 4.625p £5.56m (AQSE: AJAX)
The natural resources investment Company announced that it has entered into an Exclusivity and Binding Option Agreement with Western Metallica Resources Corp. pursuant to which Ajax has secured an exclusive and irrevocable option to acquire 100% of the issued share capital of Western Metallica, S.L., a fully owned Spanish subsidiary of Western Metallica which owns the Nueva Celti Copper Project located in Andalusia, Spain. Under the agreed commercial terms, Ajax would acquire 100% of Western Metallica, S.L. for a total consideration of US$300,000. The Company stated the proposed Acquisition reflects Ajax's strategy of acquiring advanced exploration and historically producing mineral projects with significant resource potential in attractive mining jurisdictions on favourable commercial terms.
What’s baking in the oven?
Potential IPOs:***
Dual List:***
Bravura Solutions (ASX: BVS) the global provider of enterprise software for the wealth management and funds administration industries has announced its intention to dual list on AIM. Bravura is currently listed on the Australian Securities Exchange (ASX) and Admission to AIM is being sought via the AIM Designated Market Route. No capital to be raised on Admission with a market cap on Admission of circa £500m. Expected Admission date is 28 July.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
